Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility.
Fink
J N
JN
Selim
M H
MH
Kumar
S
S
Schlaug
G
G
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator